TISHA DOOLEY: Open Payments
NPI 1881692622 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 54 payments from 13 companies in 2025. Trend: 2023 $993 · 2024 $738 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $237 |
| GlaxoSmithKline, LLC. | 12 | $224 |
| ABBVIE INC. | 14 | $199 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
| Exact Sciences Corporation | 3 | $46 |
| Antares Pharma, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
| Amgen Inc. | 2 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Abbott Laboratories | 1 | $20 |
Products named: Veozah, TRELEGY ELLIPTA, VRAYLAR, UBRELVY, FANAPT, QULIPTA, The Cologuard Plus Collection Kit, XYOSTED.
Industry payments across LA — which companies pay providers there.
